Ignore MRI, Ignore Siemens, NewPhase etc.We have a potential...

First 1813 Last

Share
Profile

Follow
Rebound985

171 Posts.

38

13/08/20

11:12

Post #: 46506155
Share

Originally posted by stevenjd: ↑

the rest, is just a matter of allowing the inevitable to come together.
A markets growing appetite to secure their seed Apple shares.

When you put the success with low field MRI, one can draw ones own conclusions to the probability of what high field MRI 2.0 results may look like. With a significant desire, of industry to replace the toxic gadolinium contrast agent. The next movement of our collaborating partner, Siemens, you can infer for yourselves.

The great thing, is that this is many dice, MRX, MRI 2.0, New phase, Low field MRI, others, multiple path to $billions.

While we acknowledged that some absolute crap like RAP with a cough cough app were trading 125m mc, a few weeks ago, it was an obvious conclusion imo that the potential of IBX should merit the 100m mc club pre trial, ie 100-150m mc, but given the excesses of the potential here, perhaps it should be the 200m mc club pre trial, based on a a fraction of the incredible blue sky that will become ballistic with either trials yielding a fair result. Yet alone, what New phase etc, come with.

And the market will gravitate on probabilities, that at least one of our dice, if not all of them, are weighted to success given the pre clinical evidence.

Just why did 75 billion dollar Siemens approach us to collaborate? Yeah, first mover advantage, with eyes on the dinner plate.

Expand

Ignore MRI, Ignore Siemens, NewPhase etc.

We have a potential replacement for gallodinium, a potential $4b market.
This alone can put the company on the map.

even if all else fails, we have a great business selling contrast agents.

IBX Price at posting: 8.6¢ Sentiment: Hold Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon